Safety of intra-arterial chemotherapy with or without osmotic blood-brain barrier disruption for the treatment of patients with brain tumors.
Uluc K, Ambady P, McIntyre MK, Tabb JP, Kersch CN, Nerison CS, Huddleston A, Liu JJ, Dogan A, Priest RA, Fu R, Prola Netto J, Siler DA, Muldoon LL, Gahramanov S, Neuwelt EA.
Uluc K, et al. Among authors: ambady p.
Neurooncol Adv. 2022 Jun 25;4(1):vdac104. doi: 10.1093/noajnl/vdac104. eCollection 2022 Jan-Dec.
Neurooncol Adv. 2022.
PMID: 35892048
Free PMC article.